453 related articles for article (PubMed ID: 16083707)
21. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study.
Luo J; Iwasaki M; Inoue M; Sasazuki S; Otani T; Ye W; Tsugane S;
Cancer Causes Control; 2007 Aug; 18(6):603-12. PubMed ID: 17401636
[TBL] [Abstract][Full Text] [Related]
22. Newly diagnosed type 2 diabetes may serve as a potential marker for pancreatic cancer.
Dankner R; Freedman LS; Gerstein HC; Roth J; Keinan-Boker L
Diabetes Metab Res Rev; 2018 Sep; 34(6):e3018. PubMed ID: 29673046
[TBL] [Abstract][Full Text] [Related]
23. New-onset type 2 diabetes mellitus--A high-risk group suitable for the screening of pancreatic cancer?
Illés D; Terzin V; Holzinger G; Kosár K; Róka R; Zsóri G; Ábrahám G; Czakó L
Pancreatology; 2016; 16(2):266-71. PubMed ID: 26777407
[TBL] [Abstract][Full Text] [Related]
24. Use of incretin agents and risk of pancreatic cancer: a population-based cohort study.
Knapen LM; van Dalem J; Keulemans YC; van Erp NP; Bazelier MT; De Bruin ML; Leufkens HG; Croes S; Neef C; de Vries F; Driessen JH
Diabetes Obes Metab; 2016 Mar; 18(3):258-65. PubMed ID: 26537555
[TBL] [
